Nobuhiko Nishijima
Kanagawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study.
Journal: JTO clinical and research reports
Published: February 12, 2026
A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer.
Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
Published: July 07, 2024
Streptococcal Toxic Shock Syndrome with Multiple Cerebral Infarctions Caused by Streptococcus dysgalactiae subsp. equisimilis: An Autopsy Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: July 03, 2024
Interstitial lung disease with prolonged fever that occurred during long-term administration of olaparib in a 74-year-old ovarian cancer patient: Radiological features and considerations for preventing delayed diagnosis.
Journal: Radiology case reports
Published: January 10, 2024
Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review.
Journal: Therapeutic advances in respiratory disease
Published: March 06, 2023
Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 31, 2019
Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.
Journal: Respiratory research
Published: October 04, 2017
XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts.
Journal: Pulmonary pharmacology & therapeutics
Published: December 29, 2016
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells.
Journal: International journal of oncology
Published: October 16, 2015
Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
Journal: Molecular cancer therapeutics
Published: January 18, 2015
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation.
Journal: BMC cancer
Published: May 13, 2014
Last Updated: 09/26/2026